AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 20,650
+100 (0.49%)
At close: Aug 6, 2025, 3:30 PM KST
Achilles Therapeutics Market Cap
AprilBio has a market cap or net worth of 452.80 billion as of August 8, 2025. Its market cap has increased by 1.94% in one year.
Market Cap
452.80B
Enterprise Value
362.95B
Revenue
29.69B
Ranking
n/a
PE Ratio
19.65
Stock Price
$20,650.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 452.80B, an increase of 97.09%. That is a compound annual growth rate of 25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 452.80B | 24.58% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 457.00T |
| SK hynix | 181.91T |
| LG Energy Solution | 90.44T |
| Samsung Biologics | 74.80T |
| Hanwha Aerospace | 49.44T |
| Hyundai Motor Company | 45.99T |
| Doosan Enerbility | 41.50T |
| HD Hyundai Heavy Industries | 41.19T |